Key Highlights

  • Fortive (NYSE:FTV) reported third quarter Revenue of USD 1,107.5 million, up 7.8% on a reported basis and 7.2% on a core basis.
  • Adjusted Diluted Earnings per Share rose 13.2% to USD 0.77, the fifth straight quarter of double digit adjusted EPS growth.
  • Full year 2026 adjusted EPS guidance was raised to USD 3.10 to USD 3.14, implying about 15% growth at the midpoint.
  • The shares were quoted at USD 86.07 in the latest session, down 2.18% on the day, within about 4% of their 52-week high.

Accelerating Core Growth Drives the Quarter

Fortive released its third quarter 2026 results on October 28, and the numbers extended a pattern of steady acceleration. Core revenue growth reached 7.2%, up from 6.7% in the second quarter, while reported revenue climbed to USD 1,107.5 million from USD 1,027.1 million a year earlier. Adjusted EBITDA rose about 10% to USD 339 million, lifting the Margin by 50 basis points to 30.6%. GAAP diluted earnings per share from continuing operations reached USD 0.57 against USD 0.35 a year earlier, helped in part by an USD 18 million Tariff refund that the company excluded from adjusted EPS. Adjusted diluted earnings per share of USD 0.77 compared with USD 0.68 in the prior year quarter. Free Cash Flow for the quarter was USD 284 million, and trailing twelve month free cash flow rose 15.2% to USD 1,062 million. Chief executive Olumide Soroye said the third quarter was another quarter of strong and accelerating performance for Fortive, a message that has supported the stock's steady move higher through the autumn.

Intelligent Operating Solutions Leads, Healthcare Lags

The Intelligent Operating Solutions segment, home to the Fluke brand, carried the quarter. Segment revenue rose 9.8% to USD 767 million, or 9.1% on a core basis, and adjusted EBITDA increased 13.6% to USD 275 million, lifting the margin 120 basis points to 35.8%. Management said the segment's book to bill ratio was above one and that orders accelerated from the second quarter, which gives investors visibility into the fourth quarter. Data Center related Demand remains a low single digit share of revenue, so the growth is broad rather than tied to one theme. The Advanced Healthcare Solutions segment was softer. Revenue rose 3.7% to USD 340 million, or 3.1% core, but adjusted EBITDA fell 4.8% to USD 88 million and the margin narrowed 230 basis points to 25.8%. Management expects price to contribute about 200 basis points in that segment through the rest of 2026 and into 2027. Adjusted gross margin across the company was about 63%, down 80 basis points on product mix, so margin progress came from cost discipline rather than gross margin gains.

Buybacks and a Higher Guide Support the Momentum

Capital returns are a central part of the Fortive Accelerated strategy. The company repurchased about USD 300 million of stock in the quarter, roughly 5 million shares or about 2% of diluted shares. Since the current company was formed after the 2025 separation, it has bought back about USD 2.3 billion of stock, or about 13% of shares outstanding. The quarterly Dividend was raised 16.7% to USD 0.07 in August. The new adjusted EPS range of USD 3.10 to USD 3.14 replaces a prior range of USD 2.95 to USD 3.05. Management now expects reported revenue just above USD 4.4 billion, core growth just above 5% and adjusted EBITDA margin expansion near the middle of a 50 to 100 basis point range. The fourth quarter has four fewer selling days than a year ago, a headwind of USD 15 million to USD 20 million to reported revenue and about 150 basis points to core growth. Gross Debt stands at about 2.6 times adjusted EBITDA, close to the company's target of around 2.5 times.

Where Things Stand

Fortive's climb toward its 52-week high rests on accelerating core growth, double digit EPS gains and heavy buybacks. The calendar headwind in the fourth quarter and softer healthcare margins are the main items to watch into the 2027 outlook.